Skip to content
Screener

Schering-Plough SGP Common Stock Shares Issued

Common Stock Shares Issued at other companies

Bausch + Lomb logo
Bausch + LombBLCO
357.1M+0.9%
HRO
HarrowHROW
37.5M+2.1%
Bausch Health Companies logo
Bausch Health CompaniesBHC
373.5M+1.1%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
43.3M+2.5%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
114M-3.0%

Other financials

Income statement

See full
Operating income-$15.4M-108%
Net income-$13.8M-56.6%
EPS (diluted)-$0.69+82.6%

Balance sheet

See full
Cash & equivalents$238.9M+312%
Total debt$1.6M
Total equity$250.1M+463%
Total assets$258.4M

Cash flow

See full
Operating cash flow-$13.5M-65.2%
CapEx$676.0K+312%
Free cash flow-$14.2M-70.0%

Valuation

See full
Market cap$841.55M+0.7%
Enterprise value$604.26M

Returns & leverage

See full
Return on equity-34.3%
Debt / equity
Current ratio38×

Where this comes from

Reported directly by Schering-Plough in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesIssued.

The source filing: Schering-Plough’s 10-K, filed March 26, 2026.

Filed
Mar 26, 2026, 5:23 PM EDT
Fiscal year
FY2025
Accession
0001778922-26-000020
(in thousands, except share and per share amounts)As of December 31, 2025As of December 31, 2024
Commitments and contingencies (Note 7)
Redeemable convertible preferred stock, $.00001 par value; 116,618,581 shares authorized, 20,341,968 and 9,608,914 shares issued and outstanding as of December 31, 2025 and 2024, respectively (aggregate liquidation preference of $200,878 and $73,542 as of December 31, 2025 and 2024, respectively)204,53772,546
Stockholders' deficit
Common stock, $.00001 par value; 154,383,336 shares authorized; 2,203,620 and 2,196,423 shares issued and outstanding as of December 31, 2025 and 2024, respectively
Common stock additional paid-in capital5,8934,387
Accumulated deficit(104,730)(64,861)
Total stockholders' deficit(98,837)(60,474)
Total liabilities, redeemable convertible preferred stock and stockholders' deficit$115,866$23,318

Item 8. [Financial Statements and Supplementary Data](#ifaf54775e85441fc836f60bc7c4f1464_4398046512509)

FAQ

What is Schering-Plough's common stock shares issued?
Schering-Plough (SGP) reported common stock shares issued of 2.2M in Q4 2025.
What does common stock shares issued mean?
The total number of shares that have been authorized and distributed by the corporation since its inception. This includes shares held by the public (outstanding) as well as any shares that the company has repurchased and holds in its treasury. It represents the historical volume of equity capital creation.

Ask your AI about Schering-Plough's common stock shares issued.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude